An Analysis of How Smoking Affects Assessments for the Cardiovascular and Autonomic Functioning: A Tertiary Care Study.

Main Article Content

Jaywant Shivaji Thorat
M. A. Doshi
Deepali Sadashiv Jankar


Introduction: Smoking is a significant risk factor for CVD, however it is unclear how smoking affects tests of cardiovascular and autonomic functioning at tertiary care facilities.

Methods: In a tertiary care context, this study looked at the relationship between smoking and tests of cardiovascular and autonomic functioning. 200 people took part in the study, 100 of whom were smokers and 100 were not. Blood pressure, heart rate, cholesterol levels, and autonomic function were assessed in the subjects.

Results: Smokers had a higher mean BMI than non-smokers (p <0.05). Other baseline characteristics were similar between groups. Smokers had greater systolic, diastolic, and heart rates than non-smokers (p<0.05). Smokers had significantly higher HDL and LDL cholesterol than non-smokers (p < 0.05). Other comparisons between the groups indicated no changes. After correcting for potential confounders, smokers had higher risks of elevated SBP (OR=2.34, 95% CI: 1.21-4.54), DBP, and HR than non-smokers. Smokers had a higher risk of low HDL cholesterol (OR=2.64, 95% CI: 1.49-4.67) and high LDL cholesterol (OR=2.49).

Conclusion: Smoking causes problems with the heart and the autonomic nervous system. There may be a dose-dependent relationship between smoking's detrimental effects on cardiovascular and autonomic function, with heavier smokers reporting more severe impairments. To lower the risk of CVD and other harmful cardiovascular events, healthcare practitioners should encourage smokers to quit.

Article Details

How to Cite
Thorat, J. S. ., Doshi, M. A. ., & Jankar, D. S. . (2023). An Analysis of How Smoking Affects Assessments for the Cardiovascular and Autonomic Functioning: A Tertiary Care Study. Journal of Coastal Life Medicine, 11(1), 2665–2671. Retrieved from


World Health Organization. WHO report on the global tobacco epidemic, 2019: Offer help to quit tobacco use. World Health Organization; 2019.

Centers for Disease Control and Prevention. Health effects of cigarette smoking. Centers for Disease Control and Prevention; 2020.

Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, et al. Heart disease and stroke statistics-2019 update: a report from the American Heart Association. Circulation. 2019;139(10):e56-e528.

Gordan R, Gwathmey JK, Xie LH. Autonomic and endocrine control of cardiovascular function. World J Cardiol. 2015;7(4):204-214. doi:10.4330/wjc.v7.i4.204.

Thayer JF, Yamamoto SS, Brosschot JF. The relationship of autonomic imbalance, heart rate variability and cardiovascular disease risk factors. International Journal of Cardiology. 2010;141(2):122-31.

Grassi G, Seravalle G, Calhoun DA, Bolla GB, Giannattasio C, Marabini M, et al. Mechanisms responsible for sympathetic activation by cigarette smoking in humans. Circulation. 1994;90(1):248-53.

Barua RS, Ambrose JA, Srivastava S, DeVoe MC, Eales-Reynolds LJ. Reactive oxygen species are involved in smoking-induced dysfunction of nitric oxide biosynthesis and upregulation of endothelial nitric oxide synthase: an in vitro demonstration in human coronary artery endothelial cells. Circulation. 2003;107(18):2342-7.

Auler JO Jr, Torres ML, Cardoso MM, et al. Clinical evaluation of the flotrac/Vigileo system for continuous cardiac output monitoring in patients undergoing regional anesthesia for elective cesarean section: a pilot study. Clinics (Sao Paulo). 2010;65(8):793-798. doi:10.1590/s1807-59322010000800009.

Arakaki X, Arechavala RJ, Choy EH, et al. The connection between heart rate variability (HRV), neurological health, and cognition: A literature review. Front Neurosci. 2023;17:1055445. Published 2023 Mar 1. doi:10.3389/fnins.2023.1055445.

Gepner AD, Piper ME, Johnson HM, Fiore MC, Baker TB, Stein JH. Effects of smoking and smoking cessation on lipids and lipoproteins: outcomes from a randomized clinical trial. American Heart Journal. 2011;161(1):145-51.

Gallucci G, Tartarone A, Lerose R, Lalinga AV, Capobianco AM. Cardiovascular risk of smoking and benefits of smoking cessation. J Thorac Dis. 2020;12(7):3866-3876. doi:10.21037/jtd.2020.02.47.

Targher G, Alberiche M, Zenere MB, Bonadonna RC, Muggeo M, Bonora E. Cigarette smoking and insulin resistance in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1997;82(11):3619-3624. doi:10.1210/jcem.82.11.4351

Zhang L, Curhan GC, Hu FB, Rimm EB, Forman JP. Association between passive and active smoking and incident type 2 diabetes in women. Diabetes Care. 2011;34(4):892-7. doi: 10.2337/dc10-2109

Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR Jr, Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation. 2000;101(9):948-954. doi:10.1161/01.cir.101.9.948.

Heitzer T, Schlinzig T, Krohn K, Meinertz T, Münzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation. 2001 Jul 31;104(22):2673-8.

Baba S, Iso H, Mannami T, et al. Cigarette smoking and risk of coronary heart disease incidence among middle-aged Japanese men and women: the JPHC Study Cohort I. Eur J Cardiovasc Prev Rehabil. 2006;13(2):207-213. doi:10.1097/01.hjr.0000194417.16638.3d.

Pomeranz B, Macaulay RJ, Caudill MA, et al. Assessment of autonomic function in humans by heart rate spectral analysis. Am J Physiol. 1985; 248(1 Pt 2): H151-H153.

Vlachopoulos C, Xaplanteris P, Aboyans V, Brodmann M, Cífková R, Cosentino F, et al. The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation. Eur J Prev Cardiol. 2020;27(2_suppl):4-24. doi: 10.1177/2047487320908385.

Khera AV, Emdin CA, Drake I, Natarajan P, Bick AG, Cook NR, et al. Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease. N Engl J Med. 2016 Dec 15;375(24):2349-2358. doi: 10.1056/NEJMoa1605086. PMID: 27959714; PMCID: PMC5241854.

Office on Smoking and Health (US). The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General. Atlanta (GA): Centers for Disease Control and Prevention (US); 2006..

Gupta, Ritesh, et al. “Smokeless Tobacco and Cardiovascular Risk.” Smokeless Tobacco and Cardiovascular Risk | Tobacco and e-Cigarettes | JAMA Internal Medicine | JAMA Network, 27 Sept. 2004,

Boffetta P, Straif K. Use of smokeless tobacco and risk of myocardial infarction and stroke: systematic review with meta-analysis. BMJ. 2009;339:b3060. doi: 10.1136/bmj.b3060.

Barutcu I, Esen AM, Kaya D, et al. Cigarette smoking and heart rate variability: dynamic influence of parasympathetic and sympathetic maneuvers. Ann Noninvasive Electrocardiol. 2005;10(3):324-329. doi:10.1111/j.1542-474X.2005.00636.x.

Pan A, Wang Y, Talaei M, Hu FB, Wu T. Relation of active, passive, and quitting smoking with incident type 2 diabetes: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2015;3(12):958-967. doi:10.1016/S2213-8587(15)00316-2.

Reeves GK, Pirie K, Beral V, et al. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ. 2007;335(7630):1134. doi:10.1136/bmj.39367.495995.AE

Hammond D, Fong GT, McNeill A, Borland R, Cummings KM. Effectiveness of cigarette warning labels in informing smokers about the risks of smoking: findings from the International Tobacco Control (ITC) Four Country Survey. Tob Control. 2006 Dec;15 Suppl 3:iii19-25. doi: 10.1136/tc.2005.012294. PMID: 17130673; PMCID: PMC2593061.

Kiyohara Y, Ueda K, Fujishima M. Smoking and cardiovascular disease in the general population in Japan. J Hypertens Suppl. 1990;8(5):S9-S15